Prognostic and diagnostic glycan-based biomarkers of brain damage
US10739335B2 · kind B2 · utility
1Cited by
1References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 14, 2016 |
| Grant date | Aug 11, 2020 |
| Priority date | — |
| Expiry date | Apr 14, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/28
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present disclosure relates to glycan-based biomarkers for the diagnosis or prognosis of brain damage, such as traumatic brain injury (TBI).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.